poorly defined disorder characterized by low serum levels of IgG and usually IgA or IgM. Common clinical picture may result from multiple mechanisms. A failure of T-cell and B-cell cooperation ...
Imvotamab is a bispecific T cell engaging IgM antibody targeting both CD3 and CD20 proteins. Management believes Imvotamab could deliver significant advantages over existing B cell therapies as it ...
This useful study reports that the exogenous expression of the microRNA miR-195 can partially compensate in early B cell development for the loss of EBF1, one of the key transcription factors in B ...
Harnessing the body's B-cells to fight tumors may be a promising treatment for glioblastoma, according to a Northwestern Medicine study recently published in the Journal of Clinical Investigation.
Diffuse large B cell lymphoma (DLBCL) is a cancer that affects white blood cells called B cell lymphocytes. Ordinarily, these cells help protect against infection and disease. In DLBCL ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...